COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 14.29
(0.0%)
CNY 14.29
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14.78 Billion CNY | 37.77% |
| 2022 | 10.69 Billion CNY | 0.72% |
| 2021 | 10.61 Billion CNY | 16.5% |
| 2020 | 9.11 Billion CNY | 7.18% |
| 2019 | 8.5 Billion CNY | 9352.04% |
| 2018 | 89.94 Million CNY | 99.4% |
| 2017 | 45.1 Million CNY | -45.26% |
| 2016 | 82.4 Million CNY | 346.05% |
| 2015 | 18.47 Million CNY | -88.73% |
| 2014 | 163.91 Million CNY | 9.0% |
| 2013 | 150.38 Million CNY | -12.98% |
| 2012 | 172.82 Million CNY | -34.24% |
| 2011 | 262.8 Million CNY | 1.68% |
| 2010 | 258.45 Million CNY | -23.48% |
| 2009 | 337.75 Million CNY | 2.58% |
| 2008 | 329.25 Million CNY | 26.29% |
| 2007 | 260.7 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -334.55 Million CNY | -318.18% |
| 2024 Q1 | -80 Million CNY | -102.46% |
| 2024 Q3 | 5.26 Billion CNY | 1673.63% |
| 2023 FY | 14.73 Billion CNY | 37.77% |
| 2023 Q3 | 3.49 Billion CNY | -16.91% |
| 2023 Q4 | 3.24 Billion CNY | -7.26% |
| 2023 Q2 | 4.21 Billion CNY | 11.65% |
| 2023 Q1 | 3.77 Billion CNY | 57.15% |
| 2022 Q4 | 2.4 Billion CNY | 4.49% |
| 2022 Q3 | 2.29 Billion CNY | -6.83% |
| 2022 Q2 | 2.46 Billion CNY | -30.14% |
| 2022 Q1 | 3.52 Billion CNY | 54.33% |
| 2022 FY | 10.69 Billion CNY | 0.72% |
| 2021 FY | 10.61 Billion CNY | 16.5% |
| 2021 Q4 | 2.28 Billion CNY | -10.53% |
| 2021 Q2 | 2.33 Billion CNY | -31.89% |
| 2021 Q1 | 3.43 Billion CNY | 67.81% |
| 2021 Q3 | 2.55 Billion CNY | 9.26% |
| 2020 FY | 9.11 Billion CNY | 7.18% |
| 2020 Q3 | 2.23 Billion CNY | 12.92% |
| 2020 Q2 | 1.97 Billion CNY | -30.77% |
| 2020 Q1 | 2.85 Billion CNY | 24.22% |
| 2020 Q4 | 2.04 Billion CNY | -8.33% |
| 2019 Q3 | 1.89 Billion CNY | 1.25% |
| 2019 FY | 8.5 Billion CNY | 9352.04% |
| 2019 Q1 | 2.48 Billion CNY | 9424.32% |
| 2019 Q2 | 1.87 Billion CNY | -24.82% |
| 2019 Q4 | 2.29 Billion CNY | 21.31% |
| 2018 FY | 89.94 Million CNY | 99.4% |
| 2018 Q4 | 26.13 Million CNY | -19.36% |
| 2018 Q3 | 32.41 Million CNY | 20.16% |
| 2018 Q2 | 26.97 Million CNY | 511.75% |
| 2018 Q1 | 4.41 Million CNY | -67.09% |
| 2017 Q4 | 13.4 Million CNY | -43.67% |
| 2017 FY | 45.1 Million CNY | -45.26% |
| 2017 Q1 | 2.61 Million CNY | -79.81% |
| 2017 Q2 | 5.3 Million CNY | 102.92% |
| 2017 Q3 | 23.78 Million CNY | 348.54% |
| 2016 Q2 | 31.27 Million CNY | 183.1% |
| 2016 FY | 82.4 Million CNY | 346.05% |
| 2016 Q4 | 12.94 Million CNY | -52.29% |
| 2016 Q3 | 27.13 Million CNY | -13.26% |
| 2016 Q1 | 11.04 Million CNY | 120.71% |
| 2015 FY | 18.47 Million CNY | -88.73% |
| 2015 Q1 | 29.94 Million CNY | -35.66% |
| 2015 Q2 | 32.76 Million CNY | 9.39% |
| 2015 Q3 | 9.11 Million CNY | -72.18% |
| 2015 Q4 | -53.35 Million CNY | -685.28% |
| 2014 Q2 | 41.57 Million CNY | 15.85% |
| 2014 FY | 163.91 Million CNY | 9.0% |
| 2014 Q3 | 39.9 Million CNY | -4.01% |
| 2014 Q1 | 35.88 Million CNY | -0.74% |
| 2014 Q4 | 46.55 Million CNY | 16.65% |
| 2013 Q2 | 36.43 Million CNY | 92.39% |
| 2013 Q1 | 18.93 Million CNY | -67.94% |
| 2013 FY | 150.38 Million CNY | -12.98% |
| 2013 Q4 | 36.15 Million CNY | -38.58% |
| 2013 Q3 | 58.85 Million CNY | 61.52% |
| 2012 Q2 | 36.33 Million CNY | -29.19% |
| 2012 FY | 172.82 Million CNY | -34.24% |
| 2012 Q4 | 59.07 Million CNY | 126.41% |
| 2012 Q3 | 26.09 Million CNY | -28.18% |
| 2012 Q1 | 51.31 Million CNY | -45.55% |
| 2011 Q2 | 71.06 Million CNY | 20.24% |
| 2011 Q1 | 59.1 Million CNY | -33.15% |
| 2011 FY | 262.8 Million CNY | 1.68% |
| 2011 Q3 | 38.39 Million CNY | -45.97% |
| 2011 Q4 | 94.23 Million CNY | 145.41% |
| 2010 FY | 258.45 Million CNY | -23.48% |
| 2010 Q1 | 72.91 Million CNY | -16.92% |
| 2010 Q2 | 43.52 Million CNY | -40.3% |
| 2010 Q3 | 53.6 Million CNY | 23.15% |
| 2010 Q4 | 88.41 Million CNY | 64.94% |
| 2009 Q3 | 86.46 Million CNY | 2.06% |
| 2009 Q1 | 78.8 Million CNY | 0.0% |
| 2009 Q2 | 84.72 Million CNY | 7.51% |
| 2009 FY | 337.75 Million CNY | 2.58% |
| 2009 Q4 | 87.76 Million CNY | 1.5% |
| 2008 FY | 329.25 Million CNY | 26.29% |
| 2007 FY | 260.7 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 39.89 Billion CNY | 62.945% |